Heroin — Competitive Intelligence Brief

Heroin (diamorphine) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Opioid Agonist. Area: Pain.

unknown Opioid Agonist Pain

Target snapshot

Heroin (diamorphine). Heroin works by binding to opioid receptors in the brain, mimicking the action of natural pain-relieving chemicals.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Heroin TARGET	diamorphine		unknown	Opioid Agonist
BENZHYDROCODONE	BENZHYDROCODONE		marketed	Opioid analgesic combination; full mu-opioid agonist with non-opioid analgesic	Mu-opioid receptors (primary); delta and kappa opioid receptors (secondary); central nervous system pain pathways	2018-01-01
Nucynta	TAPENTADOL	Collegium Pharm Inc	marketed	Opioid Agonist	Mu-type opioid receptor	2008-01-01
Alfenta	ALFENTANIL	Rising	marketed	Opioid Agonist	Mu-type opioid receptor	1986-01-01
Sufenta Preservative Free	SUFENTANIL	Rising	marketed	Opioid Agonist	Mu-type opioid receptor	1984-01-01
Dilaudid-Hp	Hydromorphone Hydrochloride	Fresenius Kabi	marketed	Opioid agonist	Mu-opioid receptor	1984-01-01
Dilaudid-Hp	HYDROMORPHONE	Fresenius Kabi	marketed	Opioid Agonist	mu-opioid receptor	1984-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Opioid Agonist class)

1. · 4 drugs in this class
2. Rising · 2 drugs in this class
3. Pfizer · 2 drugs in this class
4. Endo · 1 drug in this class
5. Fresenius Kabi · 1 drug in this class
6. Specgx Llc · 1 drug in this class
7. Teva · 1 drug in this class
8. Bausch Health · 1 drug in this class
9. Collegium Pharm Inc · 1 drug in this class